Use of Medication to Treat Attention-Deficit/Hyperactivity Disorder in Young Children: The Role of Maternal History of Psychotropic Medication Use

被引:0
|
作者
Wall-Wieler, Elizabeth [1 ,2 ]
Bolton, James M. [1 ,3 ,4 ]
Detillieux, Gilles [2 ]
Roos, Leslie L. [1 ,2 ]
机构
[1] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada
[2] Univ Manitoba, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada
[4] Univ Manitoba, Dept Psychol, Winnipeg, MB, Canada
基金
加拿大健康研究院;
关键词
ADHD; Psychotropic medication; Maternal and child health; Cohort study; ADHD; HEALTH; ASSOCIATION; ADHERENCE; DIAGNOSIS; ATTITUDES; PARENTS;
D O I
10.1007/s10578-021-01247-x
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
We examine whether, among children diagnosed with ADHD, are those whose mothers have a history of psychotropic medication use more likely to treat their ADHD with medication? Children born in Manitoba, Canada from 2000 to 2010 diagnosed with ADHD between their 4th and 8th birthday. Maternal psychotropic medication use was assessed from one year before the child's birth to the child's fourth birthday. Logistic regression models examine the relationship between maternal history of psychotropic medication use and the use of medication to treat ADHD in children. Among the 2384 children diagnosed with ADHD, the rate of ADHD medication use was higher for those whose mother had a history of psychotropic medication use (76.6%) than for those whose mothers did not (72.5%) (OR 1.24, 95% CI 1.03, 1.49). Children whose mothers have a history of psychotropic medication use are more likely to have their ADHD treated with medication.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 50 条
  • [1] Use of Medication to Treat Attention-Deficit/Hyperactivity Disorder in Young Children: The Role of Maternal History of Psychotropic Medication Use
    Elizabeth Wall-Wieler
    James M. Bolton
    Gilles Detillieux
    Leslie L. Roos
    Child Psychiatry & Human Development, 2023, 54 : 283 - 289
  • [2] Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children
    Rappley, MD
    Mullan, PB
    Alvarez, FJ
    Eneli, IU
    Wang, J
    Gardiner, JC
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1999, 153 (10): : 1039 - 1045
  • [3] Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder
    Rappley, MD
    Eneli, IU
    Mullan, PB
    Alvarez, FJ
    Wang, J
    Luo, ZH
    Gardiner, JC
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2002, 23 (01): : 23 - 30
  • [4] Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder
    Guevara, J
    Lozano, P
    Wickizer, T
    Mell, L
    Gephart, H
    PEDIATRICS, 2002, 109 (05) : 733 - 739
  • [5] Use of medication by young people with attention-deficit/hyperactivity disorder
    Sawyer, MG
    Rey, JM
    Graetz, BW
    Clark, JJ
    Baghurst, PA
    MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (01) : 21 - 25
  • [6] Medication for children with attention-deficit hyperactivity disorder
    Jensen, CE
    CLINICAL SOCIAL WORK JOURNAL, 2004, 32 (02) : 197 - 214
  • [7] Medication for Children with Attention-Deficit Hyperactivity Disorder
    Cary E. Jensen
    Clinical Social Work Journal, 2004, 32 : 197 - 214
  • [8] Concomitant psychotropic medication use in children and adolescents referred for attention deficit hyperactivity disorder
    Sarampote, CS
    Barrueco, S
    Robb, A
    Seymour, KE
    Lewis, JA
    Efron, L
    Stein, MA
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [9] Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder
    Rast, Jessica E.
    Anderson, Kristy A.
    Roux, Anne M.
    Shattuck, Paul T.
    ACADEMIC PEDIATRICS, 2021, 21 (02) : 272 - 279
  • [10] THERAPEUTICS Stimulant medication to treat attention-deficit/hyperactivity disorder
    Santosh, Paramala
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 358